Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 489

recruiting
3 968
countries
28
conditions
2 103

10 282 trials match your criteria

Countries:SpainSpain
  • Participants:18–64 years · Healthy volunteers
  • Substances:Hydrochlorothiazide
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Cytisinicline
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers

Psoriasis

Not recruiting

A study to examine how the body processes and removes DC-806 in healthy male volunteers

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Dc-806
Countries:CzechiaCzechia
  • Participants:18–64 years · Healthy volunteers
  • Substances:Perampanel

Drug level

Not recruiting

Relative bioavailability of BI 685509 tablets and the impact of food and esomeprazole on BI 685509 in healthy male volunteers

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Bi 685509

Effect of moderate or severe liver impairment on the pharmacokinetics, safety and tolerability of camizestrant in post‑menopausal women

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Camizestrant

Neoplasm malignant

Not recruiting

Phase 1 safety and dose-finding study of NG-350A plus pembrolizumab in patients with metastatic cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab

A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Paclitaxel

Asthma+1

Not recruiting

Bioequivalence study of fluticasone propionate and salmeterol xinafoate inhalation powder in healthy volunteers for asthma treatment

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · Healthy volunteers
  • Substances:Salmeterol Xinafoate

Arteriosclerosis

Not recruiting

A study to evaluate the safety of MK-1403 in healthy men for the treatment of atherosclerosis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · Healthy volunteers
Countries:CzechiaCzechia
  • Participants:18–64 years · Healthy volunteers
  • Substances:Bempedoic Acid
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.